BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan L, Han P, Ma S, Peng R, Wang C, Kong W, Cong L, Fu J, Zhang Z, Yu H, Wang Y, Jiang J. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharm Sin B 2020;10:249-61. [PMID: 32082971 DOI: 10.1016/j.apsb.2019.10.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo X, Zhou L, Wang S, Yuan J, Chang Z, Hu Q, Chen Y, Liu Y, Huang Y, Wang B, Gao Y, Wang Z, Cui Y, Liu Y, Zhang L. The Therapeutic Effect and the Potential Mechanism of Flavonoids and Phenolics of Moringa oleifera Lam. Leaves against Hyperuricemia Mice. Molecules 2022;27:8237. [DOI: 10.3390/molecules27238237] [Reference Citation Analysis]
2 Liu X, Han C, Lei K, Mao T, Yu Q, Li C, Ke L, Wu J, Guo Y, Zhang W, Tian Z. Enterococcus faecalis ameliorates hyperuricemia and maintains the epithelium barrier in a hyperuricemia mouse model.. [DOI: 10.21203/rs.3.rs-2261921/v1] [Reference Citation Analysis]
3 Yang XY, Yu H, Fu J, Guo HH, Han P, Ma SR, Pan LB, Zhang ZW, Xu H, Hu JC, Zhang HJ, Bu MM, Zhang XF, Yang W, Wang JY, Jin JY, Zhang HC, Li DR, Lu JY, Lin Y, Jiang JD, Tong Q, Wang Y. Hydroxyurea ameliorates atherosclerosis in ApoE(-/-) mice by potentially modulating Niemann-Pick C1-like 1 protein through the gut microbiota. Theranostics 2022;12:7775-87. [PMID: 36451858 DOI: 10.7150/thno.76805] [Reference Citation Analysis]
4 Liu X, Li Z, Zheng Y, Wang W, He P, Guan K, Wu T, Wang X, Zhang X. Extracellular vesicles isolated from hyperuricemia patients might aggravate airway inflammation of COPD via senescence-associated pathway. J Inflamm (Lond) 2022;19:18. [PMID: 36324164 DOI: 10.1186/s12950-022-00315-w] [Reference Citation Analysis]
5 Wang R, Halimulati M, Huang X, Ma Y, Li L, Zhang Z. Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia. Journal of Advanced Research 2022. [DOI: 10.1016/j.jare.2022.11.003] [Reference Citation Analysis]
6 Halimulati M, Wang R, Aihemaitijiang S, Huang X, Ye C, Zhang Z, He L, Zhu W, Zhang Z. Anti-Hyperuricemia Mechanism of Anserine Based on the Gut-Kidney Axis: Integrated Analyses of Metagenomic and Metabolomic.. [DOI: 10.21203/rs.3.rs-2065498/v1] [Reference Citation Analysis]
7 Bai J, Cai Y, Huang Z, Gu Y, Huang N, Sun R, Zhang G, Liu R. Shouhui Tongbian Capsule ameliorates constipation via gut microbiota-5-HT-intestinal motility axis. Biomed Pharmacother 2022;154:113627. [PMID: 36058152 DOI: 10.1016/j.biopha.2022.113627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Xu H, Pan L, Yu H, Han P, Fu J, Zhang Z, Hu J, Yang X, Keranmu A, Zhang H, Bu M, Jiang J, Wang Y. Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics. Front Pharmacol 2022;13:919181. [DOI: 10.3389/fphar.2022.919181] [Reference Citation Analysis]
9 Zou F, Zhao H, Ma A, Song D, Zhang X, Zhao X. Preparation of an isorhamnetin phospholipid complex for improving solubility and anti-hyperuricemia activity. Pharm Dev Technol 2022;:1-43. [PMID: 36083162 DOI: 10.1080/10837450.2022.2123510] [Reference Citation Analysis]
10 Sun L, Ni C, Zhao J, Wang G, Chen W. Probiotics, bioactive compounds and dietary patterns for the effective management of hyperuricemia: a review. Crit Rev Food Sci Nutr 2022;:1-16. [PMID: 36073759 DOI: 10.1080/10408398.2022.2119934] [Reference Citation Analysis]
11 Qin N, Qin M, Shi W, Kong L, Wang L, Xu G, Guo Y, Zhang J, Ma Q. Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics. Sci Rep 2022;12:13980. [PMID: 35978088 DOI: 10.1038/s41598-022-18361-y] [Reference Citation Analysis]
12 Zhou X, Zhang B, Zhao X, Lin Y, Zhuang Y, Guo J, Wang S. Chlorogenic Acid Prevents Hyperuricemia Nephropathy via Regulating TMAO-Related Gut Microbes and Inhibiting the PI3K/AKT/mTOR Pathway. J Agric Food Chem 2022. [PMID: 35950815 DOI: 10.1021/acs.jafc.2c03099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang Z, Li Y, Liao W, Huang J, Liu Y, Li Z, Tang J. Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout. Front Cell Infect Microbiol 2022;12:935723. [DOI: 10.3389/fcimb.2022.935723] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Han P, Li L, Wang Z, Xi L, Yu H, Cong L, Zhang Z, Fu J, Peng R, Pan L, Ma S, Wang X, Wang H, Wang X, Wang Y, Sun J, Jiang J. Multi-Omics Analysis Provides Insight into the Possible Molecular Mechanism of Hay Fever Based on Gut Microbiota. Engineering 2022;15:115-25. [DOI: 10.1016/j.eng.2021.03.013] [Reference Citation Analysis]
15 Xu L, Li Y, Ji J, Lai Y, Chen J, Ding T, Li H, Ding B, Ge W. The anti-inflammatory effects of Hedyotis diffusa Willd on SLE with STAT3 as a key target. Journal of Ethnopharmacology 2022. [DOI: 10.1016/j.jep.2022.115597] [Reference Citation Analysis]
16 Yu H, Fu J, Guo HH, Pan LB, Xu H, Zhang ZW, Hu JC, Yang XY, Zhang HJ, Bu MM, Lin Y, Jiang JD, Wang Y. Metabolites Analysis of Anti-Myocardial Ischemia Active Components of Saussurea involucrata Based on Gut Microbiota-Drug Interaction. Int J Mol Sci 2022;23:7457. [PMID: 35806462 DOI: 10.3390/ijms23137457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Fang X, Qi L, Chen H, Gao P, Zhang Q, Leng R, Fan Y, Li B, Pan H, Ye D. The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout. Front Nutr 2022;9:890730. [DOI: 10.3389/fnut.2022.890730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Pugin B, Plüss S, Mujezinovic D, Nielsen RC, Lacroix C. Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension. Front Microbiol 2022;13:853735. [PMID: 35495677 DOI: 10.3389/fmicb.2022.853735] [Reference Citation Analysis]
19 Mukhopadhyay S, Saha S, Chakraborty S, Prasad P, Ghosh A, Aich P. Differential colitis susceptibility of Th1- and Th2-biased mice: A multi-omics approach. PLoS ONE 2022;17:e0264400. [DOI: 10.1371/journal.pone.0264400] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Li H, Zhang H, Yan F, He Y, Ji A, Liu Z, Li M, Ji X, Li C. Kidney and plasma metabolomics provide insights into the molecular mechanisms of urate nephropathy in a mouse model of hyperuricemia. Biochim Biophys Acta Mol Basis Dis 2022;:166374. [PMID: 35276331 DOI: 10.1016/j.bbadis.2022.166374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 García C, García-villalba R, Moreno D, Tomás-barberán F. Gut Microbiota Interactions With Dietary Terpenoids and Nitrogen-Containing Phytochemicals. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00081-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chen N, Wang W, Xiang J, Li T, Wang L, Liang R, Yang B. The anti-hyperuricemic effect of flavonoid extract of saffron by-product and its pharmacokinetics in rats after oral administration. J Sep Sci 2021. [PMID: 34921740 DOI: 10.1002/jssc.202100776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wei L, Ji H, Song W, Peng S, Zhan S, Qu Y, Chen M, Zhang D, Liu S. Hypouricemic, hepatoprotective and nephroprotective roles of oligopeptides derived from Auxis thazard protein in hyperuricemic mice. Food Funct 2021;12:11838-48. [PMID: 34746942 DOI: 10.1039/d1fo02539b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Lv Y, Ren G, Ren X. Changes of Intestinal Flora and Lymphocyte Subsets in Patients with Chronic Renal Failure. Evid Based Complement Alternat Med 2021;2021:4288739. [PMID: 34764999 DOI: 10.1155/2021/4288739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Zhang L, Jing J, Han L, Wang J, Zhang W, Liu Z, Gao A. Characterization of gut microbiota, metabolism and cytokines in benzene-induced hematopoietic damage. Ecotoxicol Environ Saf 2021;228:112956. [PMID: 34781132 DOI: 10.1016/j.ecoenv.2021.112956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Hernández-Terán A, Mejía-Nepomuceno F, Herrera MT, Barreto O, García E, Castillejos M, Boukadida C, Matias-Florentino M, Rincón-Rubio A, Avila-Rios S, Mújica-Sánchez M, Serna-Muñoz R, Becerril-Vargas E, Guadarrama-Pérez C, Ahumada-Topete VH, Rodríguez-Llamazares S, Martínez-Orozco JA, Salas-Hernández J, Pérez-Padilla R, Vázquez-Pérez JA. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes. Sci Rep 2021;11:21297. [PMID: 34716394 DOI: 10.1038/s41598-021-00851-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
27 Yang HT, Xiu WJ, Liu JK, Yang Y, Hou XG, Zheng YY, Wu TT, Wu CX, Xie X. Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased. Bioengineered 2021;12:7263-75. [PMID: 34590550 DOI: 10.1080/21655979.2021.1976897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Méndez-Salazar EO, Martínez-Nava GA. Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development. Rheumatol Int 2021. [PMID: 34586473 DOI: 10.1007/s00296-021-05007-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
29 Ren Q, Cheng L, Guo F, Tao S, Zhang C, Ma L, Fu P. Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation. J Agric Food Chem 2021;69:10932-42. [PMID: 34505780 DOI: 10.1021/acs.jafc.1c03449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
30 Ni C, Li X, Wang L, Li X, Zhao J, Zhang H, Wang G, Chen W. Lactic acid bacteria strains relieve hyperuricaemia by suppressing xanthine oxidase activity via a short-chain fatty acid-dependent mechanism. Food Funct 2021;12:7054-67. [PMID: 34152353 DOI: 10.1039/d1fo00198a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
31 Xu X, Wang H, Guo D, Man X, Liu J, Li J, Luo C, Zhang M, Zhen L, Liu X. Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy. Ren Fail 2021;43:1063-75. [PMID: 34187292 DOI: 10.1080/0886022X.2021.1944875] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
32 Dong GM, Yu H, Pan LB, Ma SR, Xu H, Zhang ZW, Han P, Fu J, Yang XY, Keranmu A, Niu HT, Jiang JD, Wang Y. Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota. Molecules 2021;26:3861. [PMID: 34202717 DOI: 10.3390/molecules26133861] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Mazzini FN, Cook F, Gounarides J, Marciano S, Haddad L, Tamaroff AJ, Casciato P, Narvaez A, Mascardi MF, Anders M, Orozco F, Quiróz N, Risk M, Gutt S, Gadano A, Méndez García C, Marro ML, Penas-Steinhardt A, Trinks J. Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype. Metabolomics 2021;17:58. [PMID: 34137937 DOI: 10.1007/s11306-021-01810-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
34 Du G, Huang H, Zhu Q, Ying L. Effects of cat ownership on the gut microbiota of owners. PLoS One 2021;16:e0253133. [PMID: 34133453 DOI: 10.1371/journal.pone.0253133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Henson MA. Interrogation of the perturbed gut microbiota in gouty arthritis patients through in silico metabolic modeling. Eng Life Sci 2021;21:489-501. [PMID: 34257630 DOI: 10.1002/elsc.202100003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
36 Sato K, Yamazaki K, Kato T, Nakanishi Y, Tsuzuno T, Yokoji-Takeuchi M, Yamada-Hara M, Miura N, Okuda S, Ohno H, Yamazaki K. Obesity-Related Gut Microbiota Aggravates Alveolar Bone Destruction in Experimental Periodontitis through Elevation of Uric Acid. mBio 2021;12:e0077121. [PMID: 34061595 DOI: 10.1128/mBio.00771-21] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
37 Papamichael MM, Katsardis C, Sarandi E, Georgaki S, Frima ES, Varvarigou A, Tsoukalas D. Application of Metabolomics in Pediatric Asthma: Prediction, Diagnosis and Personalized Treatment. Metabolites 2021;11:251. [PMID: 33919626 DOI: 10.3390/metabo11040251] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
38 James A, Ke H, Yao T, Wang Y. The Role of Probiotics in Purine Metabolism, Hyperuricemia and Gout: Mechanisms and Interventions. Food Reviews International. [DOI: 10.1080/87559129.2021.1904412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
39 Wang J, Chen Y, Zhong H, Chen F, Regenstein J, Hu X, Cai L, Feng F. The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies. Crit Rev Food Sci Nutr 2021;:1-11. [PMID: 33480266 DOI: 10.1080/10408398.2021.1874287] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 21.0] [Reference Citation Analysis]
40 Gao Y, Sun J, Zhang Y, Shao T, Li H, Wang M, Zhang L, Bian H, Wen C, Xie Z, Lv H. Effect of a Traditional Chinese Medicine Formula (CoTOL) on Serum Uric Acid and Intestinal Flora in Obese Hyperuricemic Mice Inoculated with Intestinal Bacteria. Evid Based Complement Alternat Med 2020;2020:8831937. [PMID: 33424995 DOI: 10.1155/2020/8831937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Zhou X, Zhang B, Zhao X, Lin Y, Wang J, Wang X, Hu N, Wang S. Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis. Food Funct 2021;12:5637-49. [PMID: 34018499 DOI: 10.1039/d0fo03199b] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 23.0] [Reference Citation Analysis]
42 Wei B, Wang S, Wang Y, Ke S, Jin W, Chen J, Zhang H, Sun J, Henning SM, Wang J, Wang H. Gut microbiota-mediated xanthine metabolism is associated with resistance to high-fat diet-induced obesity. J Nutr Biochem 2021;88:108533. [PMID: 33250443 DOI: 10.1016/j.jnutbio.2020.108533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
43 Liu YM, Xie J, Chen MM, Zhang X, Cheng X, Li H, Zhou F, Qin JJ, Lei F, Chen Z, Lin L, Yang C, Mao W, Chen G, Lu H, Xia X, Wang D, Liao X, Yang J, Huang X, Zhang BH, Yuan Y, Cai J, Zhang XJ, Wang Y, Zhang X, She ZG, Li H. Kidney Function Indicators Predict Adverse Outcomes of COVID-19. Med (N Y) 2021;2:38-48.e2. [PMID: 33043313 DOI: 10.1016/j.medj.2020.09.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
44 Henson MA. Interrogation of the Perturbed Gut Microbiota in Gouty Arthritis Patients Through in silico Metabolic Modeling.. [DOI: 10.1101/2020.09.02.20187013] [Reference Citation Analysis]
45 Yamauchi T, Oi A, Kosakamoto H, Akuzawa-Tokita Y, Murakami T, Mori H, Miura M, Obata F. Gut Bacterial Species Distinctively Impact Host Purine Metabolites during Aging in Drosophila. iScience 2020;:101477. [PMID: 32916085 DOI: 10.1016/j.isci.2020.101477] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
46 Mazzini FN, Cook F, Gounarides J, Marciano S, Haddad L, Tamaroff AJ, Casciato P, Narvaez A, Mascardi MF, Anders M, Orozco F, Quiróz N, Risk M, Gutt S, Gadano A, Méndez García C, Marro M, Penas-steinhardt A, Trinks J. Plasma and stool metabolomic biomarkers of non-alcoholic fatty liver disease in Argentina.. [DOI: 10.1101/2020.07.30.20165308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Han B, Gong M, Li Z, Qiu Y, Zou Z. NMR-Based Metabonomic Study Reveals Intervention Effects of Polydatin on Potassium Oxonate-Induced Hyperuricemia in Rats. Oxid Med Cell Longev 2020;2020:6943860. [PMID: 32695259 DOI: 10.1155/2020/6943860] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
48 Wang Z, He B, Liu Y, Huo M, Fu W, Yang C, Wei J, Abliz Z. In situ metabolomics in nephrotoxicity of aristolochic acids based on air flow-assisted desorption electrospray ionization mass spectrometry imaging. Acta Pharm Sin B 2020;10:1083-93. [PMID: 32642414 DOI: 10.1016/j.apsb.2019.12.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
49 [DOI: 10.1101/2020.11.13.20231209] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Reference Citation Analysis]